Search Login Register

Dupuytren Contracture (Dupuytrens Contracture) Summary

Description: A fibromatosis of the palmar fascia characterized by thickening and contracture of the fibrous bands on the palmar surfaces of the hand and fingers. It arises most commonly in men between the ages of 30 and 50.

Also Known As: Dupuytrens Contracture; Dupuytren's Disease; Contracture, Dupuytren; Contracture, Dupuytren's; Dupuytren Disease Show All >>

Networked: 473 relevant articles (23 outcomes, 79 trials/studies) for this Disease

Key Drugs and Agents for Dupuytren Contracture

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Collagenases (Collagenase) : 9 outcomes 15 studies in 70 results : FDA 2
  2. Microbial Collagenase (Clostridiopeptidase A) : 6 outcomes 15 studies in 48 results : IBA
  3. Matrix Metalloproteinases : 1 outcome 1 study in 8 results : IBA
  4. Metalloproteases (Metalloproteinases) : 1 outcome in 4 results : IBA
  5. Lipids : 1 outcome in 1 result : IBA
  6. Oxidized Cellulose : 1 outcome in 1 result : IBA
  7. Collagen : 7 studies in 48 results : IBA
  8. Transforming Growth Factor beta (TGF-beta) : 3 studies in 12 results : IBA
  9. Free Radicals : 2 studies in 7 results : IBA
  10. Transforming Growth Factor beta1 (TGF beta 1) : 2 studies in 5 results : IBA
Show All >>

Diseases Related to Dupuytren Contracture

  1. Contracture
  2. Disease Progression
  3. Wounds and Injuries (Trauma)
  4. Keloid
  5. Fibrosis (Cirrhosis)
Show All >>

Key Therapies for Dupuytren Contracture

Efficacy Chart >>
  1. Injections : 3 outcomes 6 studies in 33 results
  2. Amputation : 2 outcomes in 8 results
  3. Radiotherapy : 1 outcome 1 study in 13 results
  4. External Fixators : 1 outcome 1 study in 4 results
  5. Surgical Decompression : 1 outcome 1 study in 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.